111Category: | Pharmaceuticals and Biochemicals |
|
|
CAS NO: | 61-68-7 | ||
EC NO: | 200-513-1 | ||
Molecular Formula: | C15H15NO2 | ||
Molecular Weight: | 241.2851 | ||
Specification: | USP43;BP2020;JP19;EP10;Ch.p2020 | ||
InChI: | InChI=1/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18) | ||
Packing: | 50KG/FIBER DRUM | ||
Product description: Mefenamic acid is an anti-inflammatory agent that prevents the body from producing prostaglandins, which have been suggested as a cause of PMS. By reducing the amount of prostaglandins in the body, the doctor hopes to eliminate many of the inflammatory symptoms of PMS such as breast pain, headache, swelling, and other discomforts. Mefenamic acid may also be used in the treatment of pelvic pain. Molecular formula C15H15NO2 Chemical constitution Mefenamic Acid GMP certificate number:ZJ20150175 DMF Japan registration number: 219MF10029 DMF Taiwan registration number: 1015025013 FORM 41 India registration number: BD-7 |
|||
Uses: | antipyretic analgesics | ||
Synonyms: | o-(N,N-2,3-Dimethylphenyl) Amino Benzoic Acid;N-[(2,3-DIMETHYLPHENYL)AMINO]BENZOIC ACID;N-(2,3-DIMETHYLPHENYL)ANTHRANILIC ACID;n-(2,3-xylyl)anthranilic acid;2-((2,3-dimethyl(phenyl)amino)-benzoicaci;2-((2,3-dimethylphenyl)amino)-benzoicaci;2-(2,3-Dimethylanilino)benzoic acid;2¡¯,3¡¯-dimethyl-2-diphenylaminecarboxylicaci;2-Diphenylaminecarboxylic acid, 2',3'-dimethyl-;2-[(2,3-dimethylphenyl)amino]benzoic acid; | ||
Molecular Structure: |